- All Drug Categories
- Home
- Anti-cancer Drugs
- Healthcare Products
- Medical Information
- Statement
Esbriet, as a long-term treatment for idiopathic pulmonary fibrosis (IPF), needs to be continuously used under the guidance of a doctor. Its sa...
Pirfenidone is an anti fibrotic drug used to treat idiopathic pulmonary fibrosis. It has been approved for marketing in multiple countries and ...
Mylotarg is the world's first approved antibody conjugate drug, which has undergone a unique process of delisting and re approval during its ma...
The medication time of Trabectedin should strictly follow the doctor's advice, usually administered through intravenous infusion, and the speci...
Trabectedin has not been approved for marketing in Chinese Mainland, and patients need to obtain the drug through overseas channels. 1. Curr...
The medication time of Mylotarg should strictly follow the treatment plan, usually administered through intravenous infusion. The specific medi...
Kanamab (Ilaris) is a humanized monoclonal antibody that belongs to selective IL-1 β inhibitors. It is mainly used to treat various autoimmune ...
Kanamab (Ilaris) is a selective IL-1 β inhibitor primarily used for the treatment of periodic fever syndrome and autoimmune inflammatory diseas...
Pulmozyme is suitable for cystic fibrosis patients and is administered via nebulization. The recommended daily dose is 2.5mg (1 tube) and requi...
Pulmozyme is a nebulized inhalation solution that does not contain tablet components. The standard daily dosage is 2.5mg (1 single dose vial) a...
